Your browser doesn't support javascript.
loading
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.
Francisco-Cruz, Alejandro; Rocha, Pedro; Reuben, Alexandre; Krishnan, Santhoshi N; Das, Priyam; Chen, Runzhe; Quek, Kelly; Li, Jun; Parra, Edwin R; Solis, Luisa M; Barua, Souptik; Jiang, Mei; Lazcano, Rossana; Chow, Chi-Wan; Behrens, Carmen; Gumb, Curtis; Little, Latasha; Fukuoka, Junya; Kalhor, Neda; Weissferdt, Annikka; Kadara, Humam; Heymach, John V; Swisher, Stephen; Sepesi, Boris; Rao, Arvind; Moran, Cesar; Zhang, Jianhua; Lee, J Jack; Fujimoto, Junya; Futreal, P Andrew; Wistuba, Ignacio I; Peterson, Christine B; Zhang, Jianjun.
Affiliation
  • Francisco-Cruz A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rocha P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; University of Barcelona, Barcelona, Spain.
  • Reuben A; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Krishnan SN; Department of Electrical and Computer Engineering, Rice University, Houston, Texas; Department of Computational Biology and Bioinformatics, University of Michigan, Ann Arbor, Michigan.
  • Das P; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Chen R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Quek K; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li J; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Solis LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Barua S; Department of Electrical and Computer Engineering, Rice University, Houston, Texas.
  • Jiang M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chow CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Behrens C; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gumb C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fukuoka J; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kalhor N; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Weissferdt A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadara H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heymach JV; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Swisher S; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sepesi B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rao A; Department of Electrical and Computer Engineering, Rice University, Houston, Texas; Department of Computational Biology and Bioinformatics, University of Michigan, Ann Arbor, Michigan; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Moran C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: iiwistuba@mdanderson.org.
  • Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: CBPeterson@mdanderson.org.
  • Zhang J; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: jzhang20@mdanderson.org.
Mod Pathol ; 36(1): 100028, 2023 01.
Article in En | MEDLINE | ID: mdl-36788067
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2023 Type: Article